Metir plc

0.28pAs of Sun 8 Nov 2026, 12:00 UTC

LSE:METHealthcare

Ctry United Kingdom

PE (Fwd) •••

TSR 10Y CAGR (60.09%)

Div yield —

ROE (165.34%)

Medical Devices

Beta (5Y) 1.01

PE TTM —

TSR TTM (62.07%)

Mkt cap £2.619M

ROIC (104.10%)

SE Grade™

Value

Quality

Moat

Consensus

Reference

0.267p

(3.05%)

(63.03%)

Hold 12|12|5|3|2

TTM

FYE 31 Dec GBP

FY2016

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

5Y

10Y

Peers

0.573

Revenue£M

0.519

0.560

0.596

0.639

0.675

0.700

0.739

0.769

0.819

0.879

0.612

5.42%

5.91%

54

9.00

Revenue growth%

15.75

16.87

16.12

14.09

14.27

11.28

9.00

9.39

7.37

9.91

3.23

9.39

12.68

47

12.91

Gross margin%

24.43

23.48

24.76

26.44

24.06

27.06

28.79

29.79

28.49

27.62

18.74

28.49

26.75

87

21.02

Operating margin%

15.30

17.84

19.60

19.96

18.31

16.94

18.28

17.86

20.79

21.43

11.47

18.28

18.30

72

16.04

Net margin%

13.41

14.00

13.96

13.29

14.97

14.44

13.91

12.98

10.21

9.56

28.26

12.98

13.66

73

19.12

P/E ratio (avg)x

32.33

36.12

32.76

31.27

33.67

33.00

33.91

32.13

34.37

31.40

27.80

33.00

32.88

17

27.29

EV/EBITx

36.78

36.51

40.36

39.99

47.47

47.99

52.53

55.56

61.71

64.31

11.31

55.56

47.73

39

9.74

FCF yield (avg)%

12.80

11.30

9.25

7.71

5.39

6.22

4.24

2.99

4.21

5.86

11.52

4.24

6.04

46

7.84

FCF margin%

34.19

33.26

30.97

30.99

32.20

30.68

31.26

28.78

26.62

27.09

4.92

28.78

30.98

26

1.291

FCF / Net incomex

1.811

1.674

1.563

1.359

1.261

1.300

1.281

1.137

1.216

1.198

1.098

1.216

1.290

40

11.21

ROIC%

24.46

24.75

23.30

24.57

24.52

25.83

26.87

27.85

27.58

29.63

2.04

27.58

25.29

72

25.84

Return on equity%

7.65

6.91

6.16

3.44

1.05

3.94

4.00

6.10

6.55

7.23

21.30

6.10

6.13

60

13.45

Return on assets%

17.44

16.70

18.79

17.96

18.46

17.02

18.48

19.18

16.79

14.71

23.05

17.02

17.70

64

—

EPS£

—

—

—

—

—

—

—

—

—

—

—

4.57%

3.17%

—

24.62

EPS growth%

12.76

13.04

12.79

12.56

12.49

10.71

12.22

11.54

9.13

6.20

25.53

10.71

12.35

14

—

Bookvalue per sh£

—

—

—

—

—

—

—

—

—

—

—

7.30%

6.93%

—

—

FCF per share£

—

—

—

—

—

—

—

—

—

—

—

5.22%

5.92%

—

—

Dividend per sh£

—

—

—

—

—

—

—

—

—

—

—

8.41%

9.11%

—

29.72

Div yield (avg)%

9.64

12.24

13.08

11.23

10.32

7.53

9.09

10.52

12.41

9.42

3.77

9.42

10.42

25

12.97

Payout ratio%

16.62

14.49

14.53

13.61

14.71

12.62

13.69

13.92

14.90

13.84

13.86

13.84

14.20

16

0.930

Shares (diluted)B

1.453

1.661

1.830

2.048

2.417

2.729

2.942

2.946

3.178

3.388

0.963

6.98%

8.65%

21

8.75

Buyback yield%

13.67

10.75

10.38

9.21

8.43

9.27

8.52

8.98

11.31

11.91

15.45

9.27

9.83

81

1.561

D/E ratiox

1.125

1.102

1.056

1.024

1.098

1.035

1.193

1.374

1.326

1.393

0.461

1.326

1.113

8

0.482

Enterprise value£M

0.043

0.046

0.045

0.040

0.039

0.042

0.040

0.036

0.034

0.033

0.059

(3.13%)

(3.19%)

62

0.158

LT debt£M

0.246

0.279

0.289

0.301

0.352

0.360

0.393

0.400

0.444

0.487

0.709

6.74%

8.61%

57

Peers (US$3.207M)

Cap (US$)

PE

Proteome Sciences plc

7.315M

—

Surgical Innovations…

4.079M

—

Fortis Frontier PLC

3.581M

—

IceCure Medical Ltd

3.157M

—

Capital

TTM

5Y

10Y

Leveragex

0.729

(0.234)

(0.226)

EBIT/Intx

1.249

0.198

0.189

Own earn%

(36.39)

152.23

127.35

Sh yield%

38.48

19.50

20.89

Owners

Insiders/Inst%

3.43

85.85

Short interest%

4.09

SBC / revenue%

2.90

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

12

Op margin range%

15–21

$1 testx

—

Incr. ROIC%

5

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

£0.879M

5.91%

1.00×

Cost of revenue

£0.510M

5.89%

1.00×

Operating expenses

£0.176M

5.60%

0.97×